$EVAX- 👆 Up 8% Pre-Market/Current Price $1.17 👉Personalized Cancer Vaccine Biotech w/ Q4 '23 Catalyst-8/2 👉Announces financing commitments of $20m w/ Negma Group-8/1 👉Presents promising results on EVX-B1, an AI-designed vaccine for Staphylococcus aureus-7/31